The development and application of recombinant DNA technology raise various ethical and safety concerns. The potential for unintended consequences, such as the spread of genetically modified organisms ...

This article explores the pivotal role of recombinant antibody technology in the biopharmaceutical industry, highlighting its impact on past successes and future innovations.

The advent of recombinant DNA technology and monoclonal antibody production has revolutionized the development of protein-based drugs, enabling the mass production of biologics with high purity ...

Recombinant antibody technology has helped address many problems associated with hybridoma platforms, opening the door to a new class of biologic drugs.